CWC
GILD icon

Carolinas Wealth Consulting’s Gilead Sciences GILD Stock Holding History

Carolinas Wealth Consulting’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-110
Closed -$12.3K – 361
2025
Q1 		$12.3K Sell
110
-15
-12% -$1.55K ﹤0.01% 507
2024
Q4 		$11.5K Sell
125
-334
-73% -$30.1K ﹤0.01% 528
2024
Q3 		$38.5K Buy
459
+15
+3% +$1.15K 0.01% 398
2024
Q2 		$30.5K Hold
444
– – 0.01% 431
2024
Q1 		$32.5K Buy
444
+360
+429% +$27.7K 0.01% 432
2023
Q4 		$6.8K Sell
84
-34
-29% -$2.65K ﹤0.01% 588
2023
Q3 		$9.27K Sell
118
-1,413
-92% -$109K ﹤0.01% 530
2023
Q2 		$118K Buy
1,531
+4
+0.3% +$319 0.02% 236
2023
Q1 		$127K Sell
1,527
-13
-0.8% -$1.08K 0.03% 232
2022
Q4 		$132K Sell
1,540
-4
-0.3% -$317 0.03% 218
2022
Q3 		$95K Buy
1,544
+17
+1% +$1.07K 0.02% 249
2022
Q2 		$94K Buy
1,527
+370
+32% +$22.9K 0.02% 258
2022
Q1 		$69K Sell
1,157
-19
-2% -$1.22K 0.02% 301
2021
Q4 		$85K Sell
1,176
-49
-4% -$3.38K 0.02% 282
2021
Q3 		$86K Sell
1,225
-524
-30% -$36.8K 0.02% 259
2021
Q2 		$120K Sell
1,749
-716
-29% -$47.8K 0.03% 235
2021
Q1 		$159K Buy
2,465
+11
+0.4% +$709 0.04% 196
2020
Q4 		$143K Sell
2,454
-2,969
-55% -$179K 0.04% 184
2020
Q3 		$343K Buy
5,423
+1,006
+23% +$69.8K 0.12% 82
2020
Q2 		$340K Buy
4,417
+39
+0.9% +$2.99K 0.13% 73
2020
Q1 		$328K Sell
4,378
-286
-6% -$19.8K 0.18% 65
2019
Q4 		$301K Buy
+4,664
New +$304K 0.31% 47

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carolinas Wealth Consulting's GILD Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 110 shares — an estimated $12.3K sold.

Carolinas Wealth Consulting first reported a position in GILD in Q4 2019 and held it in 22 quarters. The position peaked at $343K in Q3 2020. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 110 Gilead Sciences shares in Q2 2025, an estimated $12.3K.
  • Carolinas Wealth Consulting first reported a position in Gilead Sciences in Q4 2019 and held it in 22 quarters.
  • Carolinas Wealth Consulting's Gilead Sciences position peaked at $343K in Q3 2020.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.